• Latest Posts

Rigontec and its revolutionary RNA-based immunotherapeutics raise €4.8 Million

Life Sciences have a new big player: Joint Polish Investment Fund Management

AOP Orphan and Confluence Pharmaceuticals, together for Fragile X Syndrome

A Vaccine against Placental Malaria made with ExpreS2ion’s Protein Expression Technology

#BioFigures: 12 Key French Players launch New Immunotechnology Reference Center MI-mabs

Optibrium introduces the lastest version of StarDrop


Let’s Focus on Calypso Biotech, a New Promising Startup that Concentrates on Niche Gastro-intestinal Diseases

The World’s First €100M Microbiome-focused Venture Fund opened in France

Syngenta corn trait expansion further continues thanks the Vietnamese approval

Novartis’ Jakavi receives European Commission approval

Valneva penetrates Chinese Market thanks to a license agreement